DOCS.NYSEDoximity, INC

Form 4: Doximity Director Sells $1.5M in Class A Stock

Sentiment:

Insider Trading Report


Doximity Director Timothy S. Cabral sold 20,000 shares of Class A Common Stock for $1.5 million after converting Class B shares, pursuant to a pre-arranged trading plan.

Summary

  • Director Timothy S. Cabral reported transactions involving Doximity, Inc. securities on September 24, 2025.
  • Cabral exercised stock options for 20,000 shares of Class B Common Stock with an exercise price of $2.21 per share.
  • Subsequently, 20,000 shares of Class B Common Stock were converted into 20,000 shares of Class A Common Stock at the option of the holder.
  • Cabral then sold 20,000 shares of Class A Common Stock at a price of $75 per share, totaling $1,500,000.
  • The sale was executed automatically under a Rule 10b5-1 trading plan adopted on February 13, 2025.
  • Following these transactions, Cabral directly beneficially owns 3,221 shares of Class A Common Stock and 343,500 stock options for Class B Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading, suggesting a planned financial event rather than a reaction to adverse company news.

Positives

  • The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned diversification or liquidity event rather than a reaction to new negative information.
  • The exercise of stock options indicates the options were in-the-money, reflecting past stock price appreciation.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.

Risks

  • Perception of reduced insider confidence due to the sale of a significant number of shares.
  • Potential for short-term negative sentiment in the market if investors interpret the sale as a lack of belief in future growth, despite the 10b5-1 plan.

Future Outlook

NA

Management Comments

  • The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2025.

Industry Context

Insider sales, particularly by directors, are common events in publicly traded companies. They often occur for personal financial planning, diversification, or liquidity purposes, especially when executed under a pre-arranged Rule 10b5-1 trading plan, which helps mitigate concerns about trading on material non-public information.

Comparison to Industry Standards

  • The use of a Rule 10b5-1 trading plan aligns with best practices for corporate insiders to sell shares while avoiding accusations of insider trading, a standard adopted by many executives across various industries.
  • The conversion of Class B to Class A shares is a common mechanism in companies with dual-class stock structures, often preceding a sale to increase liquidity or meet market requirements.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantTimothy S. Cabral granted a Limited Power of Attorney to Anna Bryson and John Vaughan to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on his behalf as an officer, director, and/or securityholder of Doximity, Inc.09/03/2025Streamlines compliance with Section 16 reporting requirements for the director, ensuring timely and accurate filings.

Stakeholder Impact

  • Shareholders: May interpret the insider sale as a signal, though the 10b5-1 plan suggests a planned event. The reduction in direct equity ownership by a director could be a point of consideration.

Key Dates

DateDescription
09/02/2020Grant date of the stock option, which vested in 36 equal monthly installments.
02/13/2025Date the Rule 10b5-1 trading plan was adopted by the Reporting Person.
09/03/2025Date the Limited Power of Attorney was executed by Tim Cabral.
09/24/2025Date of the reported transactions (stock option exercise, conversion, and sale of shares).
09/26/2025Date the Form 4 was signed by the Attorney-in-Fact.
09/01/2030Expiration date of the stock option.

Recommendation

hold

The Form 4 reports a planned insider sale by a director, which, while not inherently negative due to the Rule 10b5-1 plan, does not provide new positive catalysts for the stock. The sale of a significant number of shares by a director, even for personal financial planning, typically warrants a neutral 'hold' stance as it doesn't signal strong conviction for immediate upside, nor does it indicate fundamental deterioration.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, Director, Timothy Cabral, Rule 10b5-1, Class A Common Stock, Class B Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.